Access cutting-edge retinopathy of prematurity treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Atlanta location
Access retinopathy of prematurity specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related retinopathy of prematurity treatment provided free
Check if you qualify for this retinopathy of prematurity clinical trial in Atlanta, GA
No-Cost Study Care
Local to Atlanta
Convenient for GA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Type 1 retinopathy of prematurity in zone I represents the most severe type of ROP and has the worst prognosis. It is unknown whether low-dose bevacizumab will be successful in these severe cases. Also unknown is the timing and extent of peripheral retinal vascularization after low-dose bevacizumab compared with the standard dose. The current study will evaluate whether doses of 0.063 mg and 0.25mg are effective as treatment for type 1 ROP, with ROP and retinal vessels all in zone I.
Sponsor: Jaeb Center for Health Research
Yes, this clinical trial (NCT04634578) has an active research site in Atlanta, GA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for retinopathy of prematurity treatment options in Atlanta, GA, this clinical trial (NCT04634578) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retinopathy of prematurity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all retinopathy of prematurity clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Atlanta — not just this study.
Browse Essential Tremor Trials in Atlanta →